# Dova Pharmaceuticals Inc.

Dova Pharmaceuticals Inc. is a company headquartered in Durham, NC, United States.

## Company overview

- **Legal name:** Dova Pharmaceuticals Inc.
- **Former names in filing history:** Dova Pharmaceuticals, Inc. (2016-09-23 to 2018-10-04)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Durham, NC, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001685071

## About

Dova Pharmaceuticals Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001685071, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2019-03-05, it reported annual revenue of USD 10,355,000; net income of USD -72,282,000; total assets of USD 112,169,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-12-31)

- **Revenue:** $10.4M (USD 10,355,000)
- **Net income:** -$72.3M (USD -72,282,000)
- **Total assets:** $112.2M (USD 112,169,000)
- **Cash and equivalents:** $104.6M (USD 104,566,000)
- **Operating cash flow:** -$53.7M (USD -53,666,000)

### FY2017 (period ended 2017-12-31)

- **Net income:** -$30.0M (USD -29,955,000)
- **Total assets:** $96.4M (USD 96,379,000)
- **Cash and equivalents:** $94.8M (USD 94,846,000)
- **Operating cash flow:** -$10.9M (USD -10,899,000)

## Recent SEC filings

- Form 8-K — filed 2019-11-12 — period 2019-11-09 — CURRENT REPORT
- Form 10-Q — filed 2019-11-12 — period 2019-09-30 — 10-Q
- Form 8-K — filed 2019-10-03 — period 2019-09-30 — 8-K
- Form 8-K — filed 2019-09-30 — period 2019-09-30 — 8-K
- Form 10-Q — filed 2019-08-06 — period 2019-06-30 — 10-Q
- Form 8-K — filed 2019-08-06 — period 2019-08-06 — 8-K
- Form 8-K — filed 2019-06-27 — period 2019-06-27 — 8-K
- Form 10-Q — filed 2019-05-07 — period 2019-03-31 — 10-Q
- Form 8-K — filed 2019-05-07 — period 2019-05-07 — 8-K
- Form 8-K — filed 2019-04-26 — period 2019-04-26 — 8-K
- Form DEF 14A — filed 2019-03-15 — period 2019-04-26 — DEF 14A
- Form 10-K — filed 2019-03-05 — period 2018-12-31 — 10-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/dova-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology